UNIPHARMA ApS: Financial statements 2017
CVR: 78881917
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
UNIPHARMA ApS (CVR 78881917) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK -8,902 and a net result of DKK -8,902 compared with DKK -11,000 the year before. Equity in the 2017 report amounted to DKK 72,973. The solvency ratio was 40.4%.
- Revenue
- DKK -8,902
- Gross Profit
- DKK -8,902
- Profit/Loss
- DKK -8,902
- Equity
- DKK 72,973
- Total Assets
- DKK 180,490
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | -9 t. | -9 t. | -9 t. | 73 t. | - |
| 2016 | - | -11 t. | -11 t. | 82 t. | - |
| 2015 | - | -6 t. | -6 t. | 93 t. | - |
| 2014 | - | -6 t. | -6 t. | 99 t. | - |
| 2013 | - | -6 t. | -6 t. | 105 t. | - |
Official annual report
Keep an eye on UNIPHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
UNIPHARMA ApS has published its annual report for 2016. Gross profit came to DKK -11,000, and the net result was DKK -11,000.
As of June 13, 2017, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of UNIPHARMA ApS.
About UNIPHARMA ApS
UNIPHARMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 1985. The company is under bankruptcy. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company is owned by Ebba Dorrit Reumert. According to the 2023 annual report, the company had an average of 0 employees. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2024 report amounted to DKK -124,033.